Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Bicral | Rat | 1,2-dichloroethane | increases expression | ISO | Bicral (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of GLTSCR1L mRNA | CTD | PMID:28960355 | Bicral | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of GLTSCR1L mRNA | CTD | PMID:32145629 | Bicral | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BICRAL mRNA | CTD | PMID:33387578 | Bicral | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Bicral | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Bicral (Mus musculus) | 6480464 | bisphenol S results in decreased expression of BICRAL mRNA | CTD | PMID:39298647 | Bicral | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of BICRAL mRNA | CTD | PMID:31881176 | Bicral | Rat | aflatoxin B1 | increases methylation | ISO | BICRAL (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of BICRAL intron | CTD | PMID:30157460 | Bicral | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of BICRAL mRNA | CTD | PMID:38685447 | Bicral | Rat | aristolochic acid A | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of BICRAL mRNA | CTD | PMID:33212167 | Bicral | Rat | arsane | increases methylation | ISO | BICRAL (Homo sapiens) | 6480464 | Arsenic results in increased methylation of BICRAL promoter | CTD | PMID:21291286 | Bicral | Rat | arsane | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL more ... | CTD | PMID:39836092 | Bicral | Rat | arsenic atom | increases methylation | ISO | BICRAL (Homo sapiens) | 6480464 | Arsenic results in increased methylation of BICRAL promoter | CTD | PMID:21291286 | Bicral | Rat | arsenic atom | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL more ... | CTD | PMID:39836092 | Bicral | Rat | arsenite(3-) | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to BICRAL mRNA] | CTD | PMID:32406909 | Bicral | Rat | atrazine | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Atrazine results in decreased expression of BICRAL mRNA | CTD | PMID:22378314 | Bicral | Rat | benzo[a]pyrene | increases mutagenesis | ISO | BICRAL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of BICRAL gene | CTD | PMID:25435355 | Bicral | Rat | benzo[a]pyrene | affects methylation | ISO | BICRAL (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of BICRAL intron | CTD | PMID:30157460 | Bicral | Rat | benzo[a]pyrene | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of BICRAL mRNA | CTD | PMID:21632981|PMID:26238291 | Bicral | Rat | benzo[e]pyrene | increases methylation | ISO | BICRAL (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of BICRAL intron | CTD | PMID:30157460 | Bicral | Rat | bisphenol A | increases expression | ISO | Bicral (Mus musculus) | 6480464 | bisphenol A results in increased expression of BICRAL mRNA | CTD | PMID:26063408 | Bicral | Rat | bisphenol A | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of BICRAL gene | CTD | PMID:31601247 | Bicral | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of BICRAL mRNA; bisphenol A results in decreased expression more ... | CTD | PMID:25181051|PMID:32145629 | Bicral | Rat | bisphenol F | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Bicral | Rat | butanal | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of BICRAL mRNA | CTD | PMID:26079696 | Bicral | Rat | caffeine | decreases phosphorylation | ISO | BICRAL (Homo sapiens) | 6480464 | Caffeine results in decreased phosphorylation of BICRAL protein | CTD | PMID:35688186 | Bicral | Rat | carbamazepine | affects expression | ISO | BICRAL (Homo sapiens) | 6480464 | Carbamazepine affects the expression of BICRAL mRNA | CTD | PMID:25979313 | Bicral | Rat | carbon nanotube | decreases expression | ISO | Bicral (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of BICRAL mRNA; Nanotubes, Carbon results in decreased more ... | CTD | PMID:25554681 | Bicral | Rat | cisplatin | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of BICRAL mRNA | CTD | PMID:27594783 | Bicral | Rat | dexamethasone | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Bicral | Rat | Dibutyl phosphate | affects expression | ISO | BICRAL (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of BICRAL mRNA | CTD | PMID:37042841 | Bicral | Rat | dicrotophos | increases expression | ISO | BICRAL (Homo sapiens) | 6480464 | dicrotophos results in increased expression of BICRAL mRNA | CTD | PMID:28302478 | Bicral | Rat | dorsomorphin | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Bicral | Rat | fenthion | decreases expression | ISO | Bicral (Mus musculus) | 6480464 | Fenthion results in decreased expression of BICRAL mRNA | CTD | PMID:34813904 | Bicral | Rat | FR900359 | increases phosphorylation | ISO | BICRAL (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of BICRAL protein | CTD | PMID:37730182 | Bicral | Rat | fulvestrant | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of BICRAL gene | CTD | PMID:31601247 | Bicral | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of BICRAL mRNA | CTD | PMID:33387578 | Bicral | Rat | glycidol | increases expression | EXP | | 6480464 | glycidol results in increased expression of BICRAL mRNA | CTD | PMID:24395379 | Bicral | Rat | indometacin | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] more ... | CTD | PMID:28628672 | Bicral | Rat | iron dichloride | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of BICRAL mRNA | CTD | PMID:35984750 | Bicral | Rat | leflunomide | increases expression | ISO | BICRAL (Homo sapiens) | 6480464 | leflunomide results in increased expression of BICRAL mRNA | CTD | PMID:28988120 | Bicral | Rat | maneb | multiple interactions | ISO | Bicral (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of BICRAL mRNA | CTD | PMID:36117858 | Bicral | Rat | methapyrilene | increases methylation | ISO | BICRAL (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of BICRAL intron | CTD | PMID:30157460 | Bicral | Rat | paracetamol | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of BICRAL mRNA | CTD | PMID:22230336 | Bicral | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of BICRAL mRNA | CTD | PMID:33387578 | Bicral | Rat | paraquat | multiple interactions | ISO | Bicral (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of BICRAL mRNA | CTD | PMID:36117858 | Bicral | Rat | pentachlorophenol | decreases expression | ISO | Bicral (Mus musculus) | 6480464 | Pentachlorophenol results in decreased expression of BICRAL mRNA | CTD | PMID:23892564 | Bicral | Rat | phenobarbital | affects expression | ISO | Bicral (Mus musculus) | 6480464 | Phenobarbital affects the expression of BICRAL mRNA | CTD | PMID:23091169 | Bicral | Rat | phenylmercury acetate | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of BICRAL mRNA | CTD | PMID:26272509 | Bicral | Rat | phenylmercury acetate | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Bicral | Rat | resveratrol | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of BICRAL mRNA; [Plant Extracts co-treated more ... | CTD | PMID:23557933 | Bicral | Rat | SB 431542 | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Bicral | Rat | silicon dioxide | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of BICRAL mRNA | CTD | PMID:25351596 | Bicral | Rat | sodium arsenate | increases expression | ISO | Bicral (Mus musculus) | 6480464 | sodium arsenate results in increased expression of BICRAL mRNA | CTD | PMID:39847705 | Bicral | Rat | sodium arsenite | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BICRAL more ... | CTD | PMID:39836092 | Bicral | Rat | sunitinib | increases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Sunitinib results in increased expression of BICRAL mRNA | CTD | PMID:31533062 | Bicral | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of BICRAL mRNA | CTD | PMID:34492290 | Bicral | Rat | troglitazone | decreases expression | ISO | Bicral (Mus musculus) | 6480464 | troglitazone results in decreased expression of BICRAL mRNA | CTD | PMID:28973697 | Bicral | Rat | tungsten | decreases expression | ISO | Bicral (Mus musculus) | 6480464 | Tungsten results in decreased expression of GLTSCR1L mRNA | CTD | PMID:30912803 | Bicral | Rat | valproic acid | decreases expression | ISO | BICRAL (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of BICRAL mRNA | CTD | PMID:23179753|PMID:26272509|PMID:28001369|PMID:29154799 | Bicral | Rat | valproic acid | multiple interactions | ISO | BICRAL (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















